FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Future Market Insights23h
Prefilled Syringe Drug Molecule Market to Reach USD 125,678 million by 2034 at a 6% of CAGR
The prefilled syringe drug molecule market is set for significant expansion, with projected sales increasing from USD ...